No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Induction chemotherapy with cisplatin plus gemcitabine in addition to concurrent chemotherapy improves survival for nasopharyngeal carcinoma

byTeddy Guo

September 20, 2022

in StudyGraphics

Reading Time: 1 min read

Combination avelumab and axitinib treatment of advanced type B3 thymoma and thymic carcinoma is promising as second-line treatment after standard therapy.

RelatedReports

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

August 14, 2025

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer

Chronic Disease

Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma

July 24, 2025

Quick Take: Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma

Chronic Disease

Relacorilant plus nab-paclitaxel improves survival in platinum-resistant ovarian cancer patients

July 23, 2025

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

Parental input in oncology-related palliation and pain relief for children [Classics Series]

Gender conformity influences use of laxatives and muscle-building products

Risk of myopathy and myalgia among statin users may be small and clinically insignificant

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Impact on socioeconomic status with HFrEF outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Induction chemotherapy with cisplatin plus gemcitabine in addition to concurrent chemotherapy improves survival for nasopharyngeal carcinoma

RELATED REPORTS

Combination avelumab and axitinib treatment of advanced type B3 thymoma and thymic carcinoma is promising as second-line treatment after standard therapy.

Parental input in oncology-related palliation and pain relief for children [Classics Series]

RelatedReports

Recent Reports